BioXcyte

BioXcyte is a Singapore–MIT spin-off transforming immune diagnostics with rapid, AI-powered point-of-care testing. Using proprietary microfluidic chip technology, BioXcyte analyzes immune cell activity from a single drop of whole blood and generates immune signatures in about 10 minutes. Its platform aims to give clinicians real-time immune visibility to support urgent decisions in infection, sepsis, immune dysregulation, triage, and antibiotic use—bridging the gap between early detection and timely intervention.